|
28/08/2025 07:00
Biophytis : Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
...
Lire...
28/08/2025 06:59
Biophytis : Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Press release
Biophytis Receives EMA and Belgian Regulatory
Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Paris, France, Cambridge Massachusetts, United States, August 28, 2025 – 7:00 a.m. CET
– Biophytis SA the Company, a pioneer in the development of transformative therapies...
Lire...
28/08/2025 06:57
EQS-Adhoc: PIERER Mobility AG: Results for the first half of 2025
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pEQSAdhoc: PIERER Mobility AG / Key words: Half Year Results/Forecastbr/
PIERER Mobility AG: Results for the first half of 2025 br/br/
28Aug2025 / 06:57 CET/CESTbr/
Disclosure of an inside information acc. to...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
p
EQSNews: Daldrup & Söhne AG
/ Key words: Change in Forecast/Preliminary Results
br/
Daldrup & Söhne AG increases EBIT margin and specifies EBIT forecast...
Lire...
28/08/2025 06:38
Ad hoc announcement pursuant to Art. 53 LR: Jungfraubahn Holding AG - The Jungfrau Railway Group achieves record profit in the first half of the year
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pJungfraubahn Holding AG / Key words: Half Year Resultsbr/
Ad hoc announcement pursuant to Art. 53 LR: Jungfraubahn Holding AG The Jungfrau Railway Group achieves record profit in the first half of the year...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pHelvetica Property / Key words: Funds/Half Year Resultsbr/
Helvetica Swiss Living Fund impresses in the first half of 2025 with significantly higher total profit, increased net income per unit and strong return...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pHelvetica Property / Key words: Funds/Half Year Resultsbr/
Helvetica Swiss Commercial Fund impresses in the first half of 2025 with strong net income, performance above the benchmark and successful fund merger...
Lire...
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= cellpadding= cellspacing= trtd
pCham Swiss Properties AG / Key words: Half Year Resultsbr/
Pleasing halfyear results for Cham Swiss Properties br/br/span28Aug2025 / 06:30 CET/CEST/spanbr/
Release of an ad hoc...
Lire...
28/08/2025 03:50
EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
html xmlns=http://www.w3.org/1999/xhtmlbody
table border= trtd
pEQSAdhoc: Heidelberg Pharma AG / Key words: Financingbr/
Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250CDx br/br/
28Aug2025 / 03:50...
Lire...
|